- Home
- VYGR vs PVBC Comparison
VYGR vs PVBC Comparison
Compare VYGR & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- PVBC
- Stock Information
- Founded
- VYGR 2013
- PVBC 1913
- Country
- VYGR United States
- PVBC United States
- Employees
- VYGR N/A
- PVBC N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- VYGR Health Care
- PVBC Finance
- Exchange
- VYGR Nasdaq
- PVBC Nasdaq
- Market Cap
- VYGR 206.9M
- PVBC 223.5M
- IPO Year
- VYGR 2015
- PVBC 2015
- Fundamental
- Price
- VYGR $3.36
- PVBC $12.96
- Analyst Decision
- VYGR Strong Buy
- PVBC Hold
- Analyst Count
- VYGR 7
- PVBC 1
- Target Price
- VYGR $14.50
- PVBC $12.50
- AVG Volume (30 Days)
- VYGR 725.5K
- PVBC 37.4K
- Earning Date
- VYGR 08-06-2025
- PVBC 10-23-2025
- Dividend Yield
- VYGR N/A
- PVBC N/A
- EPS Growth
- VYGR N/A
- PVBC 47.58
- EPS
- VYGR N/A
- PVBC 0.62
- Revenue
- VYGR $42,580,000.00
- PVBC $59,149,000.00
- Revenue This Year
- VYGR N/A
- PVBC $9.73
- Revenue Next Year
- VYGR $107.07
- PVBC $4.87
- P/E Ratio
- VYGR N/A
- PVBC $20.85
- Revenue Growth
- VYGR N/A
- PVBC 0.70
- 52 Week Low
- VYGR $2.65
- PVBC $10.09
- 52 Week High
- VYGR $8.28
- PVBC $13.02
- Technical
- Relative Strength Index (RSI)
- VYGR 49.16
- PVBC 64.28
- Support Level
- VYGR $3.30
- PVBC $12.48
- Resistance Level
- VYGR $3.49
- PVBC $12.99
- Average True Range (ATR)
- VYGR 0.21
- PVBC 0.17
- MACD
- VYGR -0.02
- PVBC 0.04
- Stochastic Oscillator
- VYGR 33.33
- PVBC 90.00
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.